OQO
- Product code
- OQO
- Device name
- Herpes Simplex Virus Nucleic Acid Amplification Assay
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.3305
- Medical specialty
- Microbiology
- Marketing pathway
- 510(K)
- 510(k) clearances (all years, FDA)
- 12 (all years; only the last 3 years are listed here)
FDA classification definition
A polymerase chain reaction (pcr)-based qualitative in vitro diagnostic test for the detection and typing of herpes simplex virus (hsv) dna using vaginal swab specimens.
Official FDA classification page: OQO
Classification and pathway per current FDA publications. Data from openFDA (CC0).